[go: up one dir, main page]

KR20080080539A - 암을 치료하기 위한 기타 제제와 병합한 안젤로일-치환된인게난의 용도 - Google Patents

암을 치료하기 위한 기타 제제와 병합한 안젤로일-치환된인게난의 용도 Download PDF

Info

Publication number
KR20080080539A
KR20080080539A KR1020087014304A KR20087014304A KR20080080539A KR 20080080539 A KR20080080539 A KR 20080080539A KR 1020087014304 A KR1020087014304 A KR 1020087014304A KR 20087014304 A KR20087014304 A KR 20087014304A KR 20080080539 A KR20080080539 A KR 20080080539A
Authority
KR
South Korea
Prior art keywords
cancer
cell
cells
agent
euphorbia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020087014304A
Other languages
English (en)
Korean (ko)
Inventor
안드리아스 수흐비에르
제임스 해리슨 에일워드
피터 고돈 파슨스
스티븐 마틴 옥부른
자넷 로드
다그마르 쉴-토엘너
Original Assignee
페플린 리서치 피티이 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2005906295A external-priority patent/AU2005906295A0/en
Application filed by 페플린 리서치 피티이 리미티드 filed Critical 페플린 리서치 피티이 리미티드
Publication of KR20080080539A publication Critical patent/KR20080080539A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/47Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020087014304A 2005-11-14 2006-11-14 암을 치료하기 위한 기타 제제와 병합한 안젤로일-치환된인게난의 용도 Withdrawn KR20080080539A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2005906295 2005-11-14
AU2005906295A AU2005906295A0 (en) 2005-11-14 Therapeutic formulations

Publications (1)

Publication Number Publication Date
KR20080080539A true KR20080080539A (ko) 2008-09-04

Family

ID=38022911

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020087014304A Withdrawn KR20080080539A (ko) 2005-11-14 2006-11-14 암을 치료하기 위한 기타 제제와 병합한 안젤로일-치환된인게난의 용도

Country Status (5)

Country Link
EP (1) EP1951221A1 (fr)
JP (1) JP2009516651A (fr)
KR (1) KR20080080539A (fr)
CA (1) CA2629337A1 (fr)
WO (1) WO2007053912A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ801700A0 (en) 2000-06-07 2000-06-29 Peplin Research Pty Ltd Enzyme and viral activation
CA2589992C (fr) 2004-12-13 2014-04-22 Peplin Research Pty Ltd Traitement de cancers solides
GB0525680D0 (en) 2005-12-16 2006-01-25 Peplin Ltd Therapeutic compositions
AU2008243705B2 (en) * 2007-04-30 2013-10-10 Leo Laboratories Limited Treatment of virally induced lesions
RS56337B1 (sr) 2010-04-16 2017-12-29 Leo Pharma As Ortorombični kristalni ingenol mebutat
EP2655311A1 (fr) * 2010-12-22 2013-10-30 Leo Laboratories Limited Ingénol-3-acylates i

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ801700A0 (en) * 2000-06-07 2000-06-29 Peplin Research Pty Ltd Enzyme and viral activation
AUPQ923100A0 (en) * 2000-08-07 2000-08-31 Peplin Research Pty Ltd Treatment of prostate cancer
CA2589992C (fr) * 2004-12-13 2014-04-22 Peplin Research Pty Ltd Traitement de cancers solides

Also Published As

Publication number Publication date
WO2007053912A1 (fr) 2007-05-18
EP1951221A1 (fr) 2008-08-06
CA2629337A1 (fr) 2007-05-18
JP2009516651A (ja) 2009-04-23

Similar Documents

Publication Publication Date Title
KR101487935B1 (ko) 곰보배추의 추출물 또는 이의 분획물을 유효성분으로 포함하는, stat3 매개 질환의 예방 또는 치료용 약학적 조성물
RU2712752C2 (ru) 17альфа-бензоат кортексолона для применения в лечении опухолей
KR20150091165A (ko) 항-cd38 항체 및 레날리도마이드를 포함하는 조성물
JP2022027785A5 (fr)
KR102630070B1 (ko) 알파-v 베타-3-양성인 암 줄기 세포(csc)를 표적화하여 사멸시키고 약물 내성 암을 치료하기 위한 조성물 및 방법
WO2018183089A1 (fr) Compositions pour le traitement et/ou la prévention du cancer
CN108430472A (zh) 用于治疗卵巢癌的hdac抑制剂与抗-pd-l1抗体的组合
JP2018525378A (ja) 組合せおよびその使用および処置
KR20230098279A (ko) Pdx 억제제 또는 독소루비신과 ahr 억제제의 조합
WO2018072743A1 (fr) Utilisation d'un anticorps anti-pd-1 conjugué à un inhibiteur de l'ido dans la préparation d'un médicament antitumoral
US20080214509A1 (en) Methods for enhancing the efficacy of vascular disrupting agents
JP2018522053A (ja) Tlr4アゴニストおよびその組成物ならびに癌の処置におけるそれらの使用
KR20080080539A (ko) 암을 치료하기 위한 기타 제제와 병합한 안젤로일-치환된인게난의 용도
KR20140045893A (ko) 마치현 추출물 또는 이의 분획물을 유효성분으로 포함하는 il-6 매개성 질환의 예방 또는 치료용 약학적 조성물
KR20230042034A (ko) 비만을 치료하기 위한 조성물
RU2423139C2 (ru) КОМПОЗИЦИИ, СОДЕРЖАЩИЕ Actinidia, И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
US8501792B2 (en) Treating cancer with desthiazolyl ritonavir
KR20240130081A (ko) 항-trop-2 항체-약물 접합체와 추가 치료제의 병용 사용
AU2006313017A1 (en) Use of angeloyl-substituted ingenanes in combination with other agents to treat cancer
KR102283258B1 (ko) 진세노사이드의 사이클로스포린에 의한 면역 반응 개선 용도
EP3007712B1 (fr) Traitement du cancer
WO2020135872A1 (fr) Composition pharmaceutique immunosuppressive et son application
CN112439060B (zh) Pd-l1免疫疗法的新用途
TW202404600A (zh) 使用ptpn11抑制劑及pd-1/pd-l1抑制劑之組合療法
RU2821529C2 (ru) 17a,21-диэфиры кортексолона для применения в лечении опухолей

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20080613

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid